502 abstracts found.



The molecular epidemiology of rare and compound EGFR mutations in 14,304 non-small cell lung carcinomas

Year:

Session type:

Theme:

Matthew Evans1,Brendan O'Sullivan1,Frances Hughes1,Claire Swift1,Reena Dessi1,Tina Mullis1,Matthew Smith1,Philippe Taniere1
1Queen Elizabeth Hospital Birmingham

Dosimetric analysis of VMAT for locally advanced pancreatic cancer and a novel duodenal-PTV overlap parameter as a predictor of feasibility of dose escalation

Year:

Session type:

Theme:

Paul Junni1,Ganesh Radhakrishna1
1NHS

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic nodal irradiation

Year:

Session type:

Theme:

Ciara Lyons1,Raymond King2,Sarah Osman2,Joe O'Sullivan3,Alan Hounsell3,Suneil Jain2,Conor McGarry3
1Centre for Cancer Research and Cell Biology,2Centre for Cancer Research and Cell Biology, Queen's University Belfast,3Northern Ireland Cancer Centre, Belfast Health and Social Care Trust

A higher whole pelvic integral dose is associated with worsening fatigue and functional outcome in prostate cancer patients treated with intensity modulated radiotherapy

Year:

Session type:

Theme:

Nuradh Joseph1,Tiziana Rancati2,Alessandro Cicchetti2,Riccardo Valdagni2,Jenny Chang-Claude3,Susan Davidson4,Kerstie Johnson5,Chris Talbot6,Adam Webb6,Alan McWilliam4,Catharine West7,Ananya Choudhury4
1Ministry of Health, Sri Lanka,2Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.,3German Cancer Research Center (DKFZ), Heidelberg, Germany.,4The Christie NHS Foundation Trust,5Universtiy of Leicester, United Kingdom,6University of Leicester, United Kingdom,7Institute of Cancer Sciences, University of Manchester, UK.

Enhancing responses to melanoma therapy with novel combinations of targeted therapy and immune checkpoint blockade

Year:

Session type:

Theme:

Robert Szczepaniak Sloane1,Alexandre Reuben2,Ningping Feng2,Sarah Johnson2,Jill Garvey2,Jiong Chen2,Courtney Hudgens2,Luigi Nezi2,Teresa Manzo2,Mariana Pettaccia De Macedo2,John Miller2,Jianhua Hu2,Richard Davis2,Hong Jiang2,Peter Prieto2,Timothy Heffernan2,Elizabeth Burton2,Patrick Hwu2,Hussein Tawbi2,Alexander Lazar2,Michael T. Tetzlaff2,Joe Marszalek2,Willem Overwijk2,Zachary Cooper2,Michael A. Davies2,Jennifer A. Wargo2
1UT MD Anderson Cancer Center,2MD Anderson

National Lung Matrix Trial: successful implementation of a phase II umbrella trial testing multiple genetic-marker-directed drugs in advanced non-small cell lung cancer

Year:

Session type:

Theme:

Lucinda Billingham1,Dee Wherton1,Laura Llewellyn1,Susannah Brown1,Sarah Johnson1,Peter Fletcher1,Clive Mulatero2,Timothy Yap3,Yvonne Summers4,James Spicer5,Rowena Sharpe6,Sanjay Popat7,Gary Middleton8
1Cancer Research UK Clinical Trials Unit, University of Birmingham,2Leeds Teaching Hospitals NHS Trust, Leeds,3Royal Marsden Hospital and Institute of Cancer Research, London,4The Christie NHS Foundation Trust, Manchester,5King's College London, and Guy's and St Thomas’ NHS Foundation Trust, London,6Cancer Research UK, London,7Royal Marsden Hospital and Imperial College, London,8Institute of Immunology and Immunotherapy, University of Birmingham

How to lower rate of upgrade of screen-detected high risk B3 breast lesions at time of surgery: A new proposed pathway

Year:

Session type:

Theme:

Amrita Kumar1,Chin Ng1,Mohsen Elgammal2
1Frimley Health,2

Does Medial-To-Lateral Vs Lateral-To-Medial Approach Affect Short-Term Outcomes In Laparoscopic Colorectal Surgery?

Year:

Session type:

Theme:

Anwar Hussain1,Andrew Torrance1,Saad Azhar1,Achillias Tsiamis1
1University Hospitals of North Midlands Stoke-on-Trent

The TARGET trial: molecular profiling of circulating tumour DNA to stratify patients to early phase clinical trials

Year:

Session type:

Theme:

Dominic Rothwell1,Mahmood Ayub1,Sakshi Gulati1,John Brognard1,Andrew Wallace2,Crispin Miller1,Emma J. Dean3,Natalie Cook3,Fiona Thistlethwaite3,Hui Sun Leong1,Helen Eaton2,Emma Howard2,Andrew Hudson3,Carla Siswick3,Joanne Dransfield3,Marianna Christodolou3,Nigel Smith1,Louise Carter3,Robert Metcalf3,Sreeja Aruketty3,Jaseela Chiramel3,Andrew Hughes3,Richard Marais1,Caroline Dive1,Ged Brady1,Matthew G. Krebs3
1CRUK Manchester Institute,2Central Manchester NHS Foundation Trust (CMFT),3Christie NHS Foundation Trust, Manchester

CONVERT: An international randomised trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer

Year:

Session type:

Theme:

Corinne Faivre-Finn1,Wiebke Appel2,Linda Ashcroft3,Adi Bhatnagar4,Dawn Carnell5,Angel Garcia6,Sam Guglani7,Susan Harden8,Virginia Laurence9,Mike Lind10,Paul Lorigan1,Jonathan McAleese11,Rhona McMenemin12,Nazia Mohammed13,Mary O'Brien14,Clive Peedell15,Anthony Pope16,Allan Price17,Michael Snee18,Paula Wells19,Paula Wilson20,Penella Woll21,Fiona Blackhall1
1The University of Manchester, Institute of Cancer Sciences, Manchester, UK,2Royal Preston Hospital, UK,3MAHSC-CTU, The Christie NHS Foundation Trust, UK,4Southampton General Hospital, UK,5University College London Hospitals NHS Foundation Trust, UK,6Glan Clwyd Hospital and Wrexham Maelor Hospital, UK,7Cheltenham General Hospital & Gloucestershire Royal Hospital, UK,8Addenbrookes Hospital, Cambridge, UK,9Dorset Cancer Centre, Poole, UK,10Castle Hill Hospital, Hull, UK,11Northern Ireland Cancer Centre, Belfast, UK,12Freeman Hospital, Newcastle-upon-Tyne, UK,13Beatson Cancer Centre, Glasgow, UK,14Royal Marsden Hospital, Surrey, UK,15James Cook University Hospital, Middlesbrough, UK,16The Clatterbridge Cancer Centre NHS Foundation Trust, UK,17Edinburgh Cancer Centre, UK,18St James Hospital and Bradford Royal Infirmary, Leeds, UK,19St Bartholomew's Hospital, London, UK,20Bristol Haematology & Oncology Centre, UK,21Weston Park Hospital, Sheffield, UK

Page 2 of 51« First...2...25...Last »